Now showing items 1-3 of 3
Leprosy (Hansen’s Disease): the WHO, Courage, and the Myth of ‘Elimination’
(Universala Medicina Esperanto Asocio, 2020-01-14)
Despite a significant decrease in the prevalence of Leprosy since the introduction of Multi-Drug Therapy (MDT) in the 1980s, it remains a scourge. Unfortunately the World Health Organisation (WHO) has declared the disease ...
Leukocyte and Platelet-Rich Fibrin (LPRF) Therapy & Leprosy: the Need for Caution and Research Among Marginalised Groups in Low Resource Settings
(Universala Medicina Esperanto Asocio, 2023-03-15)
This paper discusses the potential of Leukocyte and Platelet-Rich Fibrin Therapy (LPRF) to help treat ulcers and skin damage associated with leprosy. It warns that although LPRF may be a valuable and cost-effective treatment, ...
Lies, Damned Lies, Metrics & Semantics: Exploring definitions of the end of Leprosy (Hansen’s Disease) & their implications
(Radical Statistics Group, 2019)
Many a statistic is false on its face. It gets by only because the magic of numbers brings about a suspension of common sense. Leprosy (also known as Hansen’s Disease), is an infectious disease that is both potentially ...